Evidence map›Paper›PMID 39475848›Full record

ArticleJMIR cancer2024

Impact of Patient Personality on Adherence to Oral Anticancer Medications: An Opportunity?

Mahtab Jafari, Alex Shahverdian, Gelareh Sadigh, Richard A Van Etten

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JMIR cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mahtab JafariDepartment of Pharmaceutical Scienes, University of California, Irvine, Irvine, CA, United States.ORCID 0000-0002-1224-338X
Alex ShahverdianDepartment of Pharmaceutical Scienes, University of California, Irvine, Irvine, CA, United States.ORCID 0009-0002-0221-8524
Gelareh SadighDepartment of Radiological Sciences, University of California, Irvine, Orange, CA, United States.ORCID 0000-0003-3233-1878
Richard A Van EttenDepartment of Medicine, University of California, Irvine, Orange, CA, United States.ORCID 0000-0003-0000-635X

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · 1994 to 2025
$19.5M
NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

Adherence to prescribed oral anticancer therapy is an important determinant of patient outcomes, including progression-free and overall survival. While many factors (eg, medication side effects and out-of-pocket costs, problems with insurance authorization, and timely medication refills) can affect adherence, one that is relatively unexplored is the impact of a patient's attitude and personality. Patient personality influences medication adherence and persistence in nonmalignant chronic conditions such as cardiovascular disease and diabetes. In breast cancer and chronic myeloid leukemia, studies suggest that personality also affects adherence to oral chemotherapy which can be targeted to improve adherence. In this viewpoint, we highlight the opportunity of incorporating patient personality as interventions to oral cancer therapy adherence and discuss current barriers to implementation.

Indexed as

Antineoplastic AgentsMedication AdherencePersonalityAdministration, OralHumansNeoplasmsAntineoplastic Agentscancercancer medicationschemotherapyFive-Factor Modelmedication adherencemedication persistenceoncologyoral anticancer therapyType D personality

Identifiers

PMID39475848
PMCPMC11561440

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.